NUTRIENT INFORMATION
Choline1,2
Deficiencies: Healthy humans with normal folate and vitamin B-12
status who were fed a choline-deficient diet developed fatty liver,
liver damage [elevated plasma alanine (or aspartate) transaminase]
or developed muscle damage (elevated creatine phosphokinase)
that resolved when choline was restored to the diet (4,6). Elevations
in markers of DNA damage (7) and alterations in lymphocyte gene
expression (8) were also observed in choline deficiency. During
pregnancy, women in the lowest quartile of dietary choline intake
had a higher risk of having a baby with a neural tube defect (NTD)3
or cleft palate (9,10). In rodent models, maternal dietary choline
influences brain development in the fetus (11,12) and increases the
prevalence of heart defects (13).
Diet recommendations: In 1998, the U.S. Institute of Medicine’s
Food and Nutrition Board established an Adequate Intake (AI) and a
Tolerable Upper Limit (UL) for choline (14). The AI is 425 and 550
mg/d for women and men, respectively, with more recommended
during pregnancy and lactation. The AI for infants is estimated from
the calculated intake from human breast milk.
Food sources: Choline and esters of choline are widely distributed
in food; however, animal products generally contain more choline
per unit weight than plants. Eggs, beef, chicken, fish, and milk as
well as select plant foods like cruciferous vegetables and certain
beans are particularly good sources of choline providing at least
10% of the daily requirement per serving (15–18). Humans consuming an ad libitum diet ingest between 150 and 600 mg choline/d
as free choline and choline esters (10,19–23). In the 2005 NHANES
46
study, only a small portion of Americans in all age groups ate diets
that met the recommended intake for choline (24). Foods also contain the choline metabolite betaine (17), which cannot be converted
to choline but can be used as a methyl donor, thereby sparing some
choline requirements (25,26). Plant-derived foods can be a rich
source of betaine (named after beets), with grain products being
particularly good sources.
Clinical uses: Hepatic complications associated with total parenteral
nutrition (TPN), which include fatty infiltration of the liver and hepatocellular damage, have been reported by many clinical groups.
Frequently, TPN must be terminated because of the severity of the
associated liver disease. Amino acid-glucose solutions used in TPN
of humans contain no choline. The lipid emulsions used to deliver
extra calories and essential fatty acids during parenteral nutrition
contain choline in the form of phosphatidylcholine (20% emulsion
contains 13.2 mmol/L). Some of the liver disease associated with TPN
is related to choline deficiency and is prevented with supplemental
choline or phosphatidylcholine (27–31). Thus, choline is an essential
nutrient during long-term TPN.
Toxicity: The UL for choline was derived from the lowest observed
adverse effect level (hypotension) in humans and is 3.5 g/d for an
adult (14).
Recent research: Genetic variation likely underlies these differences in
dietary requirements for choline. As discussed earlier, several metabolic pathways influence how much choline is required from diet, and
single nucleotide polymorphisms in specific genes influence the efficiency of these pathways. Specifically, some polymorphisms in the
folate pathways limit the availability of methyltetrahydrofolate and
thereby increase the use of choline as a methyl donor, polymorphisms
in the PEMT gene alter endogenous synthesis of choline, and polymorphisms in other genes of choline metabolism influence dietary
requirements by changing the utilization of choline moiety (32,33).
In men, intakes exceeding the choline AI are needed to optimize
homocysteine disposal after a methionine load as well as the removal of fat from liver (34). A choline intake exceeding current
dietary recommendations was also shown to preserve markers of
cellular methylation and attenuate DNA damage in a genetic
subgroup of folate-compromised men (35).
Epidemiological studies have linked low dietary choline intake to
higher concentrations of proinflammatory markers (36,37) as well as
to increased risk of breast cancer (14) and to having a baby with a NTD
(7). Elevated NTD risk was also associated with lower concentrations of
serum total choline in a folate-fortified population (38). Additionally,
genetic variants in choline metabolizing enzymes are associated with
excess risk of NTD (39) and altered risk of breast cancer (40).
A recent study in a mouse model of Down Syndrome reported
improvements in cognitive function and emotion regulation in
©2010 American Society for Nutrition. Adv. Nutr. 1: 46–48, 2010; doi:10.3945/an.110.1010.
Downloaded from https://academic.oup.com/advances/article/1/1/46/4657096 by guest on 07 January 2023
C
holine has several important functions. It is a source of
methyl groups needed to make the primary methyl donor,
S-adenosylmethionine; a part of the neurotransmitter acetylcholine; and a component of the predominant phospholipids in
membranes (phosphatidylcholine and sphingomyelin) (1). The choline derivative, phosphatidylcholine, is a main constituent of VLDL
and is required for VLDL secretion and the export of fat from liver
(2). Betaine, formed from choline, is an important osmolyte in the
kidney glomerulus and helps with the reabsorption of water from
the kidney tubule (3). The choline moiety can be produced endogenously when phosphatidylcholine is formed from phosphatidylethanolamine, mainly in the liver. Despite this capacity to form
choline in liver, most men and postmenopausal women need to
consume choline in their diets (4); the gene for the enzyme catalyzing this biosynthesis is induced by estrogen (5) and some young
nonpregnant women may not need to eat choline (4). Genetic polymorphisms in genes of choline metabolism increase the dietary
requirement for choline and almost one-half of young women
have a gene polymorphism that makes choline biosynthesis unresponsive to estrogen, making these women’s dietary choline requirement similar to men’s.
Table 1. Dietary Reference Intake values for choline
Population
AI for infants
AI for children
AI for females
AI for pregnancy
AI for lactation
1
AI
UL
0–6 mo
125 mg/d,
18 mg/kg
150 mg/d
200 mg/d
250 mg/d
375 mg/d
550 mg/d
550 mg/d
400 mg/d
425 mg/d
450 mg/d
550 mg/d
Not possible to
establish1
6–12 mo
1–3 y
4–8 y
9–13 y
14–18 y
$19 y
14–18 y
$19 y
All ages
All ages
1000 mg/d
1000 mg/d
2000 mg/d
3000 mg/d
3500 mg/d
3000 mg/d
3500 mg/d
Age-appropriate UL
Age-appropriate UL
Source of intake should be food and formula only. From (14).
mice born to mothers supplemented with choline during the
perinatal period (41). This work expands upon earlier work in rodents showing that extra exposure to choline during the perinatal
period yielded long lasting beneficial effects on memory, learning
and attention (42).
Steven H. Zeisel*
UNC Nutrition Research Institute,
Department of Nutrition,
School of Public Health and School of Medicine,
University of North Carolina,
Chapel Hill, NC 27599
Marie A. Caudill
Division of Nutritional Sciences,
Cornell University,
Ithaca, NY 14853
1
Supported by the NIH (grant no. DK55865 to the University of
North Carolina Nutrition) and Obesity Research Center (grant no.
DK56350) and Clinical and Translational Research Center (grant
nos. M01RR00046 and UL1RR025747).
2
Author disclosures: S. H. Zeisel has no financial conflict of interest
in relation to this manuscript. Dr. Zeisel received grant support
from Mead Johnson Nutritionals, Balchem, and the Egg Nutrition
Research Center for research studies and serves on an advisory
board for Solae, Dupont, Western Almond Board, and Hershey.
M. A. Caudill has no financial conflict of interest in relation to this
manuscript. Dr. Caudill received grant support from the Egg Nutrition Research Center and from the Beef Checkoff through the National Cattlemen’s Beef Association and the Nebraska Beef Council.
3
Abbreviations used: AI, Adequate Intake; NTD, neural tube defect;
TPN, total parenteral nutrition; UL, Tolerable Upper Limit.
*
To whom correspondence should be addressed. E-mail: steven_
zeisel@unc.edu.
Literature Cited
1. Zeisel SH. Choline: critical role during fetal development
and dietary requirements in adults. Annu Rev Nutr. 2006;
26:229–50.
2. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine
is required for very low density lipoprotein secretion from rat
hepatocytes. J Biol Chem. 1988;263:2998–3004.
3. Kempson SA, Montrose MH. Osmotic regulation of renal betaine transport: transcription and beyond. Pflugers Arch. 2004;
449:227–34.
4. Fischer LM, daCosta K, Kwock L, Stewart P, Lu T-S, Stabler S,
Allen R, Zeisel S. Sex and menopausal status influence human
dietary requirements for the nutrient choline. Am J Clin Nutr.
2007;85:1275–85.
5. Resseguie M, Song J, Niculescu MD, da Costa KA, Randall TA,
Zeisel SH. Phosphatidylethanolamine N-methyltransferase
(PEMT) gene expression is induced by estrogen in human
and mouse primary hepatocytes. FASEB J. 2007;21:2622–32.
6. da Costa KA, Badea M, Fischer LM, Zeisel SH. Elevated serum
creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts. Am J Clin Nutr. 2004;
80:163–70.
7. da Costa KA, Niculescu MD, Craciunescu CN, Fischer LM, Zeisel
SH. Choline deficiency increases lymphocyte apoptosis and
DNA damage in humans. Am J Clin Nutr. 2006;84:88–94.
8. Niculescu MD, da Costa KA, Fischer LM, Zeisel SH. Lymphocyte
gene expression in subjects fed a low-choline diet differs between those who develop organ dysfunction and those who
do not. Am J Clin Nutr. 2007;86:230–9.
9. Shaw GM, Carmichael SL, Laurent C, Rasmussen SA. Maternal
nutrient intakes and risk of orofacial clefts. Epidemiology.
2006;17:285–91.
10. Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM. Periconceptional dietary intake of choline and betaine and neural
tube defects in offspring. Am J Epidemiol. 2004;160:102–9.
11. Craciunescu CN, Albright CD, Mar MH, Song J, Zeisel SH. Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. J Nutr.
2003;133:3614–8.
12. Mehedint M, Craciunescu C, Zeisel S. Maternal dietary choline
deficiency alters angiogenesis in fetal mouse hippocampus.
Proc Natl Acad Sci USA. 2010;107:12834–9.
13. Chan J, Deng L, Mikael LG, et al. Low dietary choline and low
dietary riboflavin during pregnancy influence reproductive
outcomes and heart development in mice. Am J Clin Nutr.
2010;91:1035–43.
14. Institute of Medicine, National Academy of Sciences. Choline.
Dietary reference intakes for folate, thiamin, riboflavin, niacin,
vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998. p. 390–422.
15. Caudill M. Pre- and postnatal health: evidence of increased
choline needs. J Am Diet Assoc. 2010;110:1198–206.
16. Agriculture Research Service U.S. Department of Agriculture.
USDA National Nutrient Database for Standard Reference, Release 23. 2010 [cited 2010 Jul 27].
17. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of
choline-containing compounds and betaine in common foods.
J Nutr. 2003;133:1302–7.
18. Zeisel SH, Mar M-H, Howe JC, Holden JM. Concentrations of
choline-containing compounds and betaine in common foods.
Zeisel and Caudill 47
Downloaded from https://academic.oup.com/advances/article/1/1/46/4657096 by guest on 07 January 2023
AI for males
Age
19.
20.
22.
23.
24.
25.
26.
27.
28.
29.
30.
48 Choline
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
long term parenteral nutrition and is associated with hepatic
aminotransferase abnormalities. Clin Nutr. 1993;12:33–7.
Misra S, Ahn C, Ament ME, Choi HJ, Jenden DJ, Roch M,
Buchman AL. Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study.
JPEN J Parenter Enteral Nutr. 1999;23:305–8.
da Costa KA, Kozyreva OG, Song J, Galanko JA, Fischer LM,
Zeisel SH. Common genetic polymorphisms affect the human
requirement for the nutrient choline. FASEB J. 2006;20:
1336–44.
Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc
Natl Acad Sci USA. 2005;102:16025–30.
Veenema K, Solis C, Li R, et al. Adequate Intake levels of choline are sufficient for preventing elevations in serum markers
of liver dysfunction in Mexican American men but are not
optimal for minimizing plasma total homocysteine increases
after a methionine load. Am J Clin Nutr. 2008;88:685–92.
Shin W, Yan J, Abratte CM, Vermeylen F, Caudill MA. Choline
intake exceeding current dietary recommendations preserves
markers of cellular methylation in a genetic subgroup of
folate-compromised men. J Nutr. 2010;140:975–80.
Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C,
Stefanadis C. Dietary choline and betaine intakes in relation to
concentrations of inflammatory markers in healthy adults: the
ATTICA study. Am J Clin Nutr. 2008;87:424–30.
Fargnoli JL, Fung TT, Olenczuk DM, Chamberland JP, Hu FB,
Mantzoros CS. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight
adiponectin and lower resistin concentrations in women from
the Nurses’ Health Study. Am J Clin Nutr. 2008;88:1213–24.
Shaw GM, Finnell RH, Blom HJ, et al. Choline and risk of neural
tube defects in a folate-fortified population. Epidemiology.
2009;20:714–9.
Enaw JO, Zhu H, Yang W, et al. CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California
population. BMC Med. 2006;4:36.
Xu X, Gammon MD, Zeisel SH, et al. Choline metabolism and
risk of breast cancer in a population-based study. FASEB J.
2008;22:2045–52.
Moon J, Chen M, Gandhy SU, et al. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav
Neurosci. 2010;124:346–61.
Meck WH, Williams CL. Metabolic imprinting of choline by its
availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci Biobehav
Rev. 2003;27:385–99.
Downloaded from https://academic.oup.com/advances/article/1/1/46/4657096 by guest on 07 January 2023
21.
J. Nutr. 2003;133:1302–1307. Erratum in: J Nutr. 2003;133:
2918–9.
Fischer LM, Scearce JA, Mar MH, Patel JR, Blanchard RT,
Macintosh BA, Busby MG, Zeisel SH. Ad libitum choline intake
in healthy individuals meets or exceeds the proposed adequate intake level. J Nutr. 2005;135:826–9.
Xu X, Gammon MD, Zeisel SH, Bradshaw PT, Wetmur JG,
Teitelbaum SL, Neugut AI, Santella RM, Chen J. High intakes
of choline and betaine reduce breast cancer mortality in a
population-based study. FASEB J. 2009;23:4022–8.
Bidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G.
Usual choline and betaine dietary intake and incident coronary
heart disease: the Atherosclerosis Risk in Communities (ARIC)
study. BMC Cardiovasc Disord. 2007;7:20.
Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA,
Willett WC. Dietary choline and betaine assessed by foodfrequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am
J Clin Nutr. 2006;83:905–11.
Konstantinova SV, Tell GS, Vollset SE, Ulvik A, Drevon CA,
Ueland PM. Dietary patterns, food groups, and nutrients as
predictors of plasma choline and betaine in middle-aged
and elderly men and women. Am J Clin Nutr. 2008;88:1663–9.
Jensen HH, Batres-Marquez SP, Carriquiry A, Schalinske KL.
Choline in the diets of the U.S. population: NHANES, 2003–
2004. FASEB J. 2007;21:lb219.
Craig SA. Betaine in human nutrition. Am J Clin Nutr. 2004;80:
539–49.
Dilger RN, Garrow TA, Baker DH. Betaine can partially spare
choline in chicks but only when added to diets containing a
minimal level of choline. J Nutr. 2007;137:2224–8.
Buchman A, Dubin M, Moukarzel A, Jenden D, Roch M, Rice K,
Gornbein J, Ament M. Choline deficiency: a cause of hepatic
steatosis during parenteral nutrition that can be reversed with
intravenous choline supplementation. Hepatology. 1995;22:
1399–403.
Buchman AL, Ament ME, Sohel M, Dubin M, Jenden DJ, Roch M,
Pownall H, Farley W, Awal M, Ahn C. Choline deficiency causes
reversible hepatic abnormalities in patients receiving parenteral
nutrition: proof of a human choline requirement: a placebocontrolled trial. JPEN J Parenter Enteral Nutr. 2001;25:260–8.
Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K,
Gornbein J, Ament ME, Eckhert CD. Lecithin increases plasma
free choline and decreases hepatic steatosis in long-term total
parenteral nutrition patients. Gastroenterolog. 1992;102:
1363–70.
Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K, Ament
ME. Low plasma free choline is prevalent in patients receiving